SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11514144
Source:
http://linkedlifedata.com/resource/pubmed/id/11514144
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002520
,
umls-concept:C0029277
,
umls-concept:C0038760
,
umls-concept:C0178696
,
umls-concept:C0220781
,
umls-concept:C0243071
,
umls-concept:C0243077
,
umls-concept:C1412804
,
umls-concept:C1441547
,
umls-concept:C1883254
pubmed:issue
16
pubmed:dateCreated
2001-8-21
pubmed:abstractText
A discussion of the solid-phase synthesis of ornithine derived sulfonamide hydroxamic acids is illustrated. These analogues are shown to be potent, non-peptide inhibitors of procollagen C-proteinase (PCP).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11514144
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9107377
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids
,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Protein 1
,
http://linkedlifedata.com/resource/pubmed/chemical/Bone Morphogenetic Proteins
,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxamic Acids
,
http://linkedlifedata.com/resource/pubmed/chemical/Metalloendopeptidases
,
http://linkedlifedata.com/resource/pubmed/chemical/Ornithine
,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfonamides
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0960-894X
pubmed:author
pubmed-author:ChanC SCS
,
pubmed-author:DankwardtS MSM
,
pubmed-author:DelaetN GNG
,
pubmed-author:MartinR LRL
,
pubmed-author:RobinsonL ALA
,
pubmed-author:Van WartH EHE
,
pubmed-author:WalkerK AKA
pubmed:issnType
Print
pubmed:day
20
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2085-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:11514144-Amino Acids
,
pubmed-meshheading:11514144-Bone Morphogenetic Protein 1
,
pubmed-meshheading:11514144-Bone Morphogenetic Proteins
,
pubmed-meshheading:11514144-Enzyme Inhibitors
,
pubmed-meshheading:11514144-Hydroxamic Acids
,
pubmed-meshheading:11514144-Metalloendopeptidases
,
pubmed-meshheading:11514144-Ornithine
,
pubmed-meshheading:11514144-Sulfonamides
pubmed:year
2001
pubmed:articleTitle
Amino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-proteinase: solid-phase synthesis of ornithine analogues.
pubmed:affiliation
Roche Bioscience, Inflammatory Diseases Unit, 3401 Hillview Ave, Palo Alto, CA 94304, USA. sharon.dankwardt@roche.com
pubmed:publicationType
Journal Article